MAM
Gulf Air Holidays introduces Bahrain Formula One packages
MUMBAI: Gulf Air Holidays has put together an additional, but limited number of competitively-priced, last-minute packages to allow race fans to catch three full days of the Gulf Air Bahrain Formula1 Grand Prix action. The contest will be held from 1 April to 3 April.
“Given the premium on accommodation in Bahrain, we are delighted to announce that we have managed to secure a few more rooms on top of the 100 we announced last week,” says Gulf Air Holidays manager Mark Senior.
Prices start from QR 2,455 for four night, five day packages inclusive of: return Economy Class ?ights, four nights accommodation in a three hallmark hotel on a room only or bed and breakfast basis each morning, meet and greet service on arrival, return seat in coach transfers from Bahrain International Airport to hotel, return seat in coach transfers from hotel to Bahrain International Circuit and tickets for the Victory Grandstand on all three days of the Grand Prix. Seats can also be arranged for the University Grandstand, Turn 1 Grandstand, Main Grandstand or Oasis Grandstand, informs an official release.
World champion Michael Schumacher, who had a tough time with the opening races, is planning a fight back in Bahrain with his new Ferrari car. Meanwhile, Team McLaren Mercedes confirmed that Juan Pablo Montoya wouldn’t take part in the 2005 Bahrain Grand Prix due to an injury he sustained. The Colombian’s place will be taken by Spanish reserve driver Pedro de la Rosa.
Bookings can be made either through your local travel agent, Gulf Air or by visiting www.gulfairco.com.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
